Ropes & Gray represented GHO Capital Partners and Ampersand Capital Partners in the transaction, and Cooley represented Avid Bioservices, Inc. GHO Capital Partners, LP (“GHO Capital”),...
You must be a Standard 1 Year member to access this content.
Sidley Austin is representing Nektar Therapeutics in the transaction, and Goodwin Procter is representing Ampersand Capital Partners. Ampersand has agreed to acquire Nektar’s commercial-scale manufacturing facility...
You must be a Standard 1 Year member to access this content.
Quinz advised Ampersand Capital on its investment. P95 BV, a global provider of epidemiology and clinical research solutions focused on vaccines and infectious diseases, has announced...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Ampersand Capital Partners on the deal. Ampersand Capital Partners announced its first and only closing of Ampersand 2022 Limited Partnership with $1.2 billion in...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery and Pier11 advised Ampersand Capital Partners on the deal. Ampersand Capital Partners announced the acquisition of a minority stake in BioEcho Life...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented Ampersand Capital Partners in the transaction. Ampersand Capital Partners, a healthcare-focused private equity fund, and KKR, a leading global investment firm, finalized...
You must be a Standard 1 Year member to access this content.
